Categories: NewsSeniors

Extendicare Announces January 2023 Dividend of C$0.04 per Share

MARKHAM, Ontario, Jan. 16, 2023 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of January 2023, which is payable on February 15, 2023 to shareholders of record at the close of business on January 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services to a network of 103 long-term care homes and retirement communities (53 owned/50 contract services), provide approximately 9.2 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 107,000 beds across Canada. Extendicare proudly employs approximately 19,000 qualified, highly trained and dedicated individuals who are passionate about providing high quality care and services to help people live better.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions “anticipate”, “believe”, “estimate”, “expect”, “intend”, “objective”, “plan”, “project”, “will” or other similar expressions or the negative thereof. These forward-looking statements reflect the Company’s current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare’s website at www.extendicare.com.

Extendicare contact:

Jillian E. Fountain
Vice President, Investor Relations
Phone: (905) 470-5534
Email: jfountain@extendicare.com
www.extendicare.com

Staff

Recent Posts

South Shore Family Practice Saves Up to Two Hours Daily on Clinical Documentation with eClinicalWorks and Sunoh.ai

The Michigan-based family practice utilizes the AI-powered medical scribe to save 50% of documentation time…

32 mins ago

Innovaccer Expands its HXP Capabilities with the Launch of AI-Powered Healthcare Contact Center

The contact center solution is ushering in a new era of healthcare, by driving next-level…

33 mins ago

Prevencio Selected for Prestigious MedTech Innovator 2024 Accelerator Cohort

KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc., a leader in AI-powered blood tests for cardiovascular diagnostics, has been…

35 mins ago

Veterinary Practice Management Software Market to be Worth $674.5 Million by 2031- Exclusive Report by Meticulous Research®

REDDING, Calif., June 5, 2024 /PRNewswire/ -- According to a new market research report titled, "Veterinary Practice…

41 mins ago

Ambulatory EHR Market to be Worth $7.84 billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., June 5, 2024 /PRNewswire/ -- According to a new market research report, "Ambulatory EHR…

41 mins ago

Enspectra Health Receives FDA Breakthrough Device Designation for AI-powered Imaging Platform Targeting Skin Cancer

MOUNTAIN VIEW, Calif., June 5, 2024 /PRNewswire/ -- Enspectra Health, a health tech company, today…

41 mins ago